These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24931538)

  • 21. Current considerations in the treatment of generalized anxiety disorder.
    Katzman MA
    CNS Drugs; 2009; 23(2):103-20. PubMed ID: 19173371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-Antidepressant Treatment of Generalized Anxiety Disorder.
    Zahreddine N; Richa S
    Curr Clin Pharmacol; 2015; 10(2):86-96. PubMed ID: 23438725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term goals in the management of acute and chronic anxiety disorders.
    Kjernisted KD; Bleau P
    Can J Psychiatry; 2004 Mar; 49(3 Suppl 1):51S-63S. PubMed ID: 15147036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New approaches to the pharmacological management of generalized anxiety disorder.
    Buoli M; Caldiroli A; Caletti E; Paoli RA; Altamura AC
    Expert Opin Pharmacother; 2013 Feb; 14(2):175-84. PubMed ID: 23282069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacological treatment of generalized anxiety disorders: rationale and limitations].
    Boulenger JP; Capdevielle D
    Encephale; 2007; 33(1):84-94. PubMed ID: 17457298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacotherapy of generalized anxiety disorder: focus and update on pregabalin.
    Both C; Kojda G; Lange-Asschenfeldt C
    Expert Rev Neurother; 2014 Jan; 14(1):29-38. PubMed ID: 24308277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological treatment of generalized anxiety disorder.
    Reinhold JA; Mandos LA; Rickels K; Lohoff FW
    Expert Opin Pharmacother; 2011 Nov; 12(16):2457-67. PubMed ID: 21950420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anxiety disorders: does one treatment fit all?
    Baldwin D
    Int J Psychiatry Clin Pract; 2004; 8 Suppl 1():31-5. PubMed ID: 24930687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of generalized anxiety disorder in primary care: identifying the challenges and unmet needs.
    Davidson JR; Feltner DE; Dugar A
    Prim Care Companion J Clin Psychiatry; 2010; 12(2):. PubMed ID: 20694114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of generalized anxiety disorders].
    Etchegaray M; Hardy P
    Presse Med; 2008 May; 37(5 Pt 2):859-66. PubMed ID: 18378113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnitude of potentially inappropriate prescribing in Germany among older patients with generalized anxiety disorder.
    Berger A; Mychaskiw M; Dukes E; Edelsberg J; Oster G
    BMC Geriatr; 2009 Jul; 9():31. PubMed ID: 19635161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options.
    Garakani A; Murrough JW; Freire RC; Thom RP; Larkin K; Buono FD; Iosifescu DV
    Front Psychiatry; 2020; 11():595584. PubMed ID: 33424664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence-Based Pharmacotherapy of Generalised Anxiety Disorder: Focus on Agomelatine.
    Stein DJ
    Adv Ther; 2021 Sep; 38(Suppl 2):52-60. PubMed ID: 34417992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological Treatment of Generalised Anxiety Disorder: Current Practice and Future Directions.
    Fagan HA; Baldwin DS
    Expert Rev Neurother; 2023 Jun; 23(6):535-548. PubMed ID: 37183813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of duloxetine in the treatment of anxiety disorders.
    De Berardis D; Serroni N; Carano A; Scali M; Valchera A; Campanella D; D'Albenzio A; Di Giuseppe B; Moschetta FS; Salerno RM; Ferro FM
    Neuropsychiatr Dis Treat; 2008 Oct; 4(5):929-35. PubMed ID: 19183783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Term Pharmacological Treatments of Anxiety Disorders: An Updated Systematic Review.
    Perna G; Alciati A; Riva A; Micieli W; Caldirola D
    Curr Psychiatry Rep; 2016 Mar; 18(3):23. PubMed ID: 26830881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An Algorithm for Generalized Anxiety Disorder.
    Abejuela HR; Osser DN
    Harv Rev Psychiatry; 2016; 24(4):243-56. PubMed ID: 27384395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacotherapy of generalized anxiety disorder.
    Allgulander C; Baldwin DS
    Mod Trends Pharmacopsychiatry; 2013; 29():119-27. PubMed ID: 25225022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of pregabalin in the treatment of generalized anxiety disorder.
    Baldwin DS; Ajel K
    Neuropsychiatr Dis Treat; 2007 Apr; 3(2):185-91. PubMed ID: 19300552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort study.
    Berger A; Edelsberg J; Bollu V; Alvir JM; Dugar A; Joshi AV; Oster G
    BMC Psychiatry; 2011 Dec; 11():193. PubMed ID: 22151689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.